Organo Corporation
6368
Classifica tra le azioni
#4351
Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and... Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.
Prezzo delle azioni
$15.75
Capitalizzazione di mercato
$3.62B
Variazione (1 giorno)
-3.21%
Variazione (1 anno)
-80.63%
Paese
JP
Scambia Organo Corporation (6368)
Categoria
Industrials
Rapporto P/E per Organo Corporation (6368)
Rapporto P/E al October 2026 TTM: 20.16
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Organo Corporation, il rapporto P/E attuale (TTM) è 20.16. Alla fine del 2024, il rapporto P/E era 19.63.
Storico del rapporto P/E per Organo Corporation da 2005 a 2026
Rapporto P/E alla fine di ogni anno
| Anno | Rapporto P/E | Cambia |
|---|---|---|
| 2026 (TTM) | 20.16 | 66.31% |
| 2025 | 12.12 | -38.24% |
| 2024 | 19.63 | 39.29% |
| 2023 | 14.10 | 11.69% |
| 2022 | 12.62 | 17.22% |
| 2021 | 10.77 | 23.00% |
| 2020 | 8.75 | 6.26% |
| 2019 | 8.24 | -38.03% |
| 2018 | 13.29 | 26.10% |
| 2017 | 10.54 | 9.35% |
| 2016 | 9.64 | -66.25% |
| 2015 | 28.56 | -31.42% |
| 2014 | 41.64 | 268.44% |
| 2013 | 11.30 | -5.69% |
| 2012 | 11.98 | -35.64% |
| 2011 | 18.62 | -66.72% |
| 2010 | 55.95 | 191.12% |
| 2009 | 19.22 | 10.86% |
| 2008 | 17.34 | -18.94% |
| 2007 | 21.38 | -35.56% |
| 2006 | 33.18 | 102.24% |
| 2005 | 16.41 | 0.00% |
Rapporto P/E per aziende simili o concorrenti
| Azienda | P/E Ratio | Differenza del P/E Ratio | Il paese |
|---|---|---|---|
| - | - |
US
|
|
| 26.81 | 33.00% |
DE
|
|
| - | - |
FR
|
|
| - | - |
DE
|
|
| 33.09 | 64.17% |
US
|
Come leggere un P/E ratio?
Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.
Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.
Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.